Publications, Pharmaceutical

An Eye on the Future of Preservative-Free Drops

In this article, Alexandra Ritter, Head of Regulatory Affairs and Combination Products, and Matthias Birkhoff, Vice-President Business Development, both at Aptar Pharma, discuss the value that Aptar Pharma’s regulatory support and services add to the filing process of a new eye care development, the challenges of administering a wider range of medications via topical eye drops and the benefits of preservative-free multidose ophthalmic drug-device combination products.

 
For more information on ONdrugDelivery.

 

Download Publication
Author(s): Alexandra Ritter Matthias Birkhoff
15 Mar 2022

Learn more about Ophthalmic Squeeze Dispenser

Find Out More About OSD

This Might Also Be of Your Interest

13 Dec 2021

Towards A New Standard of Care with Aptar Pharma’s Digital Health

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
2 Nov 2021

Successfully Balancing The Needs of The Planet With The Needs of The Patient

Publications, Pharmaceutical, Product Solutions, Sustainability, Innovation & Insights, Device Innovations

Read More
2 Jun 2021

Aptar Pharma discusses how digital solutions improve patient outcomes

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
10 Feb 2021

Ocular Drug Delivery: an Interesting Past with a Fascinating Future

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3 4 5 6

How Can We Help?

Back To Top